In principle, tumor cells induce minimum immune responses in the tumor microenvironment due to their lack of expression of costimulatory molecules along with class I and II MHC molecules, which disables the triggering of tumor antigen-specific T-cell responses (6, 13). The gene discussed is HLA-C; the disease is neoplasm.